22 December 2005
The impact of rosiglitazone on cardiovascular responses and endurance during isometric exercise in patients with Type 2 Diabetes.
Jerrold Scott Petrofsky, Scott LeeMed Sci Monit 2006; 12(1): CR21-26 :: ID: 443185
HTML version available soon